These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 17412850

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term combination antipsychotic treatment in VA patients with schizophrenia.
    Kreyenbuhl J, Valenstein M, McCarthy JF, Ganoczy D, Blow FC.
    Schizophr Res; 2006 May; 84(1):90-9. PubMed ID: 16631354
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL, Meterko M, Williams S, Young GJ, Baker E, Chou CH, Kilbourne AM, Bauer MS.
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.
    Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S.
    J Clin Psychiatry; 2001 Jul; 62(7):545-51. PubMed ID: 11488366
    [Abstract] [Full Text] [Related]

  • 9. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S, Leslie DL, Rosenheck RA.
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [Abstract] [Full Text] [Related]

  • 10. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.
    Clark RE, Bartels SJ, Mellman TA, Peacock WJ.
    Schizophr Bull; 2002 Jun; 28(1):75-84. PubMed ID: 12047024
    [Abstract] [Full Text] [Related]

  • 11. Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.
    Kadra G, Stewart R, Shetty H, Downs J, MacCabe JH, Taylor D, Hayes RD.
    Schizophr Res; 2016 Jul; 174(1-3):106-112. PubMed ID: 27091655
    [Abstract] [Full Text] [Related]

  • 12. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R, Olfson M.
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.
    Ren XS, Kazis LE, Lee AF, Huang YH, Hamed A, Cunningham F, Herz L, Miller DR.
    Schizophr Res; 2005 Sep 15; 77(2-3):167-77. PubMed ID: 15894460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
    Janssen B, Gaebel W, Haerter M, Komaharadi F, Lindel B, Weinmann S.
    Psychopharmacology (Berl); 2006 Aug 15; 187(2):229-36. PubMed ID: 16710714
    [Abstract] [Full Text] [Related]

  • 20. Patients with schizophrenia at risk for excessive antipsychotic dosing.
    Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S.
    J Clin Psychiatry; 2000 May 15; 61(5):344-8. PubMed ID: 10847308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.